4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001213900-25-084700
Director sold 6,700,000 shares at $3.09 ($20,703,000)
From the SEC's structured data for this filing
Trades in this filing
M33 Growth I L.P. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-04 | Sale : show line 1 in the form | −6,018,168 | $3.09 | $18,596,139 | 7,932,389 | D |
| 2025-09-04 | Sale : show line 2 in the form | −681,832 | $3.09 | $2,106,861 | 590,892 | I |
| Open-market sales · 6,700,000 sh · avg $3.09 · $20,703,000 | ||||||
Loading xslF345X05/ownership.xml…